- Conditions
- Major Depressive Disorder
- Interventions
- Selegiline Transdermal System, Placebo
- Drug
- Lead sponsor
- Somerset Pharmaceuticals
- Industry
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 308 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 20
- States / cities
- Dothan, Alabama • National City, California • San Diego, California + 17 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Healthy
- Interventions
- EMSAM (Selegiline Transdermal System) 6mg, EMSAM (Selegiline Transdermal System) 12mg
- Drug
- Lead sponsor
- Somerset Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007
- U.S. locations
- 1
- States / cities
- Honolulu, Hawaii
- Conditions
- Cocaine-Related Disorders
- Interventions
- Selegiline
- Drug
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 269 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2001
- U.S. locations
- 16
- States / cities
- Tucson, Arizona • Berkeley, California • Los Angeles, California + 11 more
- Conditions
- Major Depression
- Interventions
- Selegiline Transdermal System
- Drug
- Lead sponsor
- Somerset Pharmaceuticals
- Industry
- Eligibility
- 65 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 15
- States / cities
- Chula Vista, California • San Diego, California • Upland, California + 11 more
- Conditions
- Healthy
- Interventions
- EMSAM (Selegiline Transdermal System) 6mg/24Hr, EMSAM (Selegiline Transdermal System) 9mg/24Hr, EMSAM (Selegiline Transdermal System) 12mg/24hr
- Drug
- Lead sponsor
- Somerset Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2007
- U.S. locations
- 2
- States / cities
- Scottsdale, Arizona • St. Petersburg, Florida